{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:37:11Z","timestamp":1778812631469,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.amjcard.2022.11.022","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T17:15:13Z","timestamp":1671297313000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Single Center Experience of Percutaneous Septal Ablation in Patients With Hypertrophic Cardiomyopathy With A Novel Agent: Polidocanol"],"prefix":"10.1016","volume":"190","author":[{"given":"Ahmet Hakan","family":"Ate\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5151-5133","authenticated-orcid":false,"given":"Yusuf Ziya","family":"\u015eener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Levent","family":"\u015eahiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erg\u00fcn Bar\u0131\u015f","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kudret","family":"Aytemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2022.11.022_bib0001","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jacc.2017.02.080","article-title":"Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a word of endorsement","volume":"70","author":"Liebregts","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0002","first-page":"e783","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007673","article-title":"Guideline-based referral for septal reduction therapy in obstructive hypertrophic cardiomyopathy is associated with excellent clinical outcomes","volume":"12","author":"Kimmelstiel","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0004","article-title":"Glue septal ablation: a promising alternative to alcohol septal ablation","volume":"5","author":"Okutucu","year":"2016","journal-title":"JRSM Cardiovasc Dis"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0005","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1097\/00042728-200712000-00006","article-title":"Evaluation of the sclerotherapeutic efficacy of ethanol, polidocanol, and OK-432 using an in vitro model","volume":"33","author":"Mol","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0006","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.bjps.2014.02.022","article-title":"Polidocanol injection for chemical delay and its effect on the survival of rat dorsal skin flaps","volume":"67","author":"Menev\u015fe","year":"2014","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0007","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1093\/ehjci\/jeac008","article-title":"Brockenbrough-Braunwald-Morrow sign and Valsalva manoeuvre: how to unmask dynamic left ventricular outflow tract obstruction","volume":"23","author":"Mabalukwa","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0008","first-page":"375","article-title":"Alcohol septal ablation for hypertrophic cardiomyopathy: indications and technique","volume":"66","author":"Holmes","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0009","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O'Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/eurheartj\/ehm632","article-title":"Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up","volume":"29","author":"Durand","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0011","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1583\/03-1171MR.1","article-title":"Percutaneous transluminal septal artery ablation using polyvinyl alcohol foam particles for septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: acute and 3-year outcomes","volume":"11","author":"Gross","year":"2004","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0012","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacc.2010.07.055","article-title":"Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months\u2019 follow-up in 19 patients","volume":"57","author":"Lawrenz","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0013","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1540-8183.2010.00605.x","article-title":"Cyanoacrylate for septal ablation in hypertrophic cardiomyopathy","volume":"24","author":"Oto","year":"2011","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0014","first-page":"557","article-title":"Septal reduction therapy using nonalcohol agent in hypertrophic obstructive cardiomyopathy: single center experience","volume":"92","author":"Asil","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0015-6264(77)80202-2","article-title":"Safety testing of alkyl polyethoxylate nonionic surfactants. I. Acute effects","volume":"15","author":"Benke","year":"1977","journal-title":"Food Cosmet Toxicol"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0016","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1517\/13543780903376163","article-title":"Polidocanol for endovenous microfoam sclerosant therapy","volume":"18","author":"Eckmann","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0017","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.107.738740","article-title":"Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"118","author":"Sorajja","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0018","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00392-021-01847-6","article-title":"Alcohol-induced right bundle branch block is associated with a benign outcome in HOCM after alcohol septum ablation (ASA)","volume":"111","author":"Lawin","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.amjcard.2022.11.022_bib0019","article-title":"Contrast-induced nephropathy in patients undergoing percutaneous coronary intervention","volume":"19","author":"Shoukat","year":"2010","journal-title":"Cardiol Res Pract"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914922012176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914922012176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:44:27Z","timestamp":1757573067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914922012176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":19,"alternative-id":["S0002914922012176"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2022.11.022","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single Center Experience of Percutaneous Septal Ablation in Patients With Hypertrophic Cardiomyopathy With A Novel Agent: Polidocanol","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2022.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}